IGM Biosciences to Present at the 2021 Cantor Virtual Global Healthcare Conference

Rhea-AI Summary

IGM Biosciences announced its participation at the 2021 Cantor Virtual Global Healthcare Conference scheduled for September 29, 2021, at 3:20 p.m. EDT. The live presentation will be accessible via a webcast on the company’s website, specifically in the Investors section. IGM Biosciences is focused on developing engineered IgM antibodies and has created a proprietary platform since its establishment. A replay of the event will be available for 90 days post-presentation.

MOUNTAIN VIEW, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that management will present at the 2021 Cantor Virtual Global Healthcare Conference on September 29, 2021 at 3:20 p.m. EDT.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact
Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

FAQ

When will IGM Biosciences present at the Cantor Virtual Global Healthcare Conference?

IGM Biosciences will present at the Cantor Virtual Global Healthcare Conference on September 29, 2021, at 3:20 p.m. EDT.

How can I access the IGM Biosciences conference presentation?

The presentation can be accessed via a live webcast on the Events and Presentations page in the Investors section of the IGM Biosciences website.

How long will the IGM Biosciences webcast be available for replay?

The webcast will be archived and available for replay for 90 days following the presentation.

What is the focus of IGM Biosciences?

IGM Biosciences focuses on creating and developing engineered IgM antibodies, overcoming manufacturing and engineering challenges.